gip/glp-1 agonist GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should Know Mechanisms of action of GLP-1
Description
Foundayo offers practical advantages: no needles, no refrigeration required, and no weekly injections to track
In recent years, GLP-1RAs have made significant advancements in the treatment of diabetes
Exenatide has been observed to accumulate in the brain parenchyma of rodent models, and lixisenatide has demonstrated relatively rapid CNS penetration, likely due to its smaller size, lack of extensive protein binding, and susceptibility to endocytosis [70]
Int J Mol Med 2017;39:102936.ArticlePubMed 57
Along those lines, Kornelius et al
